Cystic Fibrosis Clinical Trial
Official title:
Evaluating the Feasibility of Interactive Mobile Health Information to Enhance Patient Care at a Cystic Fibrosis Center
Real-world adherence to inhaled and oral therapies for cystic fibrosis (CF) patients remains
discouragingly low, ranging between 31-53% for inhaled antibiotics and 41-72% for hypertonic
saline. Programs to enhance adherence, including comprehensive behavioral interventions with
adolescents, have met with mixed success. Advances in therapy, treatment delivery systems,
and data capture technology offer the potential for enhancing adherence by providing
immediate and more frequent feedback to the patient regarding his or her fidelity to the
prescribed treatment regimen. The investigators propose to evaluate a systematic yet
technically simple approach to linking treatment and feedback components to enhance adherence
in a real-work CF clinic setting that treats a significant minority patient population.
This is the first trial assessing the impact of a collaborative active intervention program
of a multi disciplinary team in improving adherence to specific chronic medications and
improving clinical outcomes in CF patients. The PI has implemented the texting service
(Caremessage.org) with COPD and diabetes patients. The content will be modified to provide
both English and Spanish language content relevant to these participants and their standard
treatment protocols.
This study will evaluate the effectiveness of an interactive mobile health information
service in supporting clinic staff (i.e., nurse practitioners, case managers and care
coordinators) at a Cystic Fibrosis Center clinic to connect with patients and create
conversations around behavior-centered goals. The interactive mobile health information
service has been designed to supplement the standard of care by supporting
patient-empowerment strategies through:
- educating participants,
- encouraging behavior change, and
- promoting adherence with their treatment protocols.
The project will adapt the iCAN program content as an educational tool to be incorporated in
the educational material. iCAN is an electronic platform aimed to provide an engaging
environment for diabetic outpatients to self-manage, gain control over their health, and
ultimately adhere to their medical appointments and regimen. Similar to diabetes, CF is an
all-encompassing chronic disease that requires coordinated efforts among patients,
caregivers, and health-care providers across treatment adherence, nutrition, lifestyle
choices, and social support systems. Central to the mobile health information service is the
interactive and personalized text-based message system that delivers actionable and tailored
health content to participants: office visit appointment reminders; medication adherence
reminders; and general health education messages. While a number of technically sophisticated
applications exist, our approach will involve a less sophisticated and complex approach. Our
primary objective is to get the information to the patients, some of whom are members of
lower income minority communities. If "simple" interventions prove effective, then the
groundwork will have been laid for considering more tailored albeit complex systems.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04696198 -
Thoracic Mobility in Cystic Fibrosis Care
|
N/A | |
Completed |
NCT00803205 -
Study of Ataluren (PTC124™) in Cystic Fibrosis
|
Phase 3 | |
Terminated |
NCT04921332 -
Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD
|
N/A | |
Completed |
NCT03601637 -
Safety and Pharmacokinetic Study of Lumacaftor/Ivacaftor in Participants 1 to Less Than 2 Years of Age With Cystic Fibrosis, Homozygous for F508del
|
Phase 3 | |
Terminated |
NCT02769637 -
Effect of Acid Blockade on Microbiota and Inflammation in Cystic Fibrosis (CF)
|
||
Recruiting |
NCT06012084 -
The Development and Evaluation of iCF-PWR for Healthy Siblings of Individuals With Cystic Fibrosis
|
N/A | |
Recruiting |
NCT06030206 -
Lung Transplant READY CF 2: A Multi-site RCT
|
N/A | |
Recruiting |
NCT06032273 -
Lung Transplant READY CF 2: CARING CF Ancillary RCT
|
N/A | |
Recruiting |
NCT06088485 -
The Effect of Bone Mineral Density in Patients With Adult Cystic Fibrosis
|
||
Recruiting |
NCT05392855 -
Symptom Based Performance of Airway Clearance After Starting Highly Effective Modulators for Cystic Fibrosis (SPACE-CF)
|
N/A | |
Recruiting |
NCT04039087 -
Sildenafil Exercise: Role of PDE5 Inhibition
|
Phase 2/Phase 3 | |
Recruiting |
NCT04056702 -
Impact of Triple Combination CFTR Therapy on Sinus Disease.
|
||
Completed |
NCT04058548 -
Clinical Utility of the 1-minute Sit to Stand Test as a Measure of Submaximal Exercise Tolerance in Patients With Cystic Fibrosis During Acute Pulmonary Exacerbation
|
N/A | |
Completed |
NCT04038710 -
Clinical Outcomes of Triple Combination Therapy in Severe Cystic Fibrosis Disease.
|
||
Completed |
NCT03637504 -
Feasibility of a Mobile Medication Plan Application in CF Patient Care
|
N/A | |
Recruiting |
NCT03506061 -
Trikafta in Cystic Fibrosis Patients
|
Phase 2 | |
Completed |
NCT03566550 -
Gut Imaging for Function & Transit in Cystic Fibrosis Study 1
|
||
Recruiting |
NCT04828382 -
Prospective Study of Pregnancy in Women With Cystic Fibrosis
|
||
Completed |
NCT04568980 -
Assessment of Contraceptive Safety and Effectiveness in Cystic Fibrosis
|
||
Recruiting |
NCT04010253 -
Impact of Bronchial Drainage Technique by the Medical Device Simeox® on Respiratory Function and Symptoms in Adult Patients With Cystic Fibrosis
|
N/A |